Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
7.42
+0.05 (0.68%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Myriad Genetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 837.6 | 753.2 | 678.4 | 690.6 | 557 | Upgrade
|
| Revenue Growth (YoY) | 11.21% | 11.03% | -1.77% | 23.99% | -12.78% | Upgrade
|
| Cost of Revenue | 252.2 | 236.2 | 202 | 197.6 | 178.2 | Upgrade
|
| Gross Profit | 585.4 | 517 | 476.4 | 493 | 378.8 | Upgrade
|
| Selling, General & Admin | 560 | 572.9 | 514.7 | 537.8 | 500.7 | Upgrade
|
| Research & Development | 113.4 | 88.7 | 85.4 | 81.9 | 72.9 | Upgrade
|
| Operating Expenses | 673.4 | 661.6 | 600.1 | 619.7 | 573.6 | Upgrade
|
| Operating Income | -88 | -144.6 | -123.7 | -126.7 | -194.8 | Upgrade
|
| Interest Expense | -2.8 | -2.9 | -3.2 | -6.6 | -11.2 | Upgrade
|
| Interest & Investment Income | 1.7 | 2.5 | 2.6 | 0.7 | 2 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.1 | -3.4 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.5 | 0.6 | -0.6 | 15.3 | Upgrade
|
| EBT Excluding Unusual Items | -90.2 | -147.9 | -123.7 | -133.2 | -188.7 | Upgrade
|
| Merger & Restructuring Charges | 2.2 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -1.8 | -90.4 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -1.5 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -12.4 | - | - | 151.6 | - | Upgrade
|
| Asset Writedown | -44.4 | - | -16.9 | - | -8 | Upgrade
|
| Legal Settlements | 21.3 | -112.8 | - | -62 | - | Upgrade
|
| Other Unusual Items | - | - | - | -11.7 | 3.4 | Upgrade
|
| Pretax Income | -123.5 | -262.2 | -140.6 | -57.1 | -283.7 | Upgrade
|
| Income Tax Expense | 3.8 | 1.1 | -28.6 | -29.9 | -59.9 | Upgrade
|
| Earnings From Continuing Operations | -127.3 | -263.3 | -112 | -27.2 | -223.8 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0.1 | Upgrade
|
| Net Income | -127.3 | -263.3 | -112 | -27.2 | -223.7 | Upgrade
|
| Net Income to Common | -127.3 | -263.3 | -112 | -27.2 | -223.7 | Upgrade
|
| Shares Outstanding (Basic) | 91 | 83 | 81 | 78 | 75 | Upgrade
|
| Shares Outstanding (Diluted) | 91 | 83 | 81 | 78 | 75 | Upgrade
|
| Shares Change (YoY) | 9.42% | 2.73% | 3.33% | 4.31% | 0.64% | Upgrade
|
| EPS (Basic) | -1.41 | -3.18 | -1.39 | -0.35 | -2.99 | Upgrade
|
| EPS (Diluted) | -1.41 | -3.18 | -1.39 | -0.35 | -2.99 | Upgrade
|
| Free Cash Flow | -27.7 | -174.1 | -151.6 | 0.6 | -40.1 | Upgrade
|
| Free Cash Flow Per Share | -0.31 | -2.10 | -1.88 | 0.01 | -0.54 | Upgrade
|
| Gross Margin | 69.89% | 68.64% | 70.22% | 71.39% | 68.01% | Upgrade
|
| Operating Margin | -10.51% | -19.20% | -18.23% | -18.35% | -34.97% | Upgrade
|
| Profit Margin | -15.20% | -34.96% | -16.51% | -3.94% | -40.16% | Upgrade
|
| Free Cash Flow Margin | -3.31% | -23.11% | -22.35% | 0.09% | -7.20% | Upgrade
|
| EBITDA | -26.8 | -88.4 | -71 | -63.9 | -123.4 | Upgrade
|
| EBITDA Margin | -3.20% | -11.74% | -10.47% | -9.25% | -22.15% | Upgrade
|
| D&A For EBITDA | 61.2 | 56.2 | 52.7 | 62.8 | 71.4 | Upgrade
|
| EBIT | -88 | -144.6 | -123.7 | -126.7 | -194.8 | Upgrade
|
| EBIT Margin | -10.51% | -19.20% | -18.23% | -18.35% | -34.97% | Upgrade
|
| Revenue as Reported | - | - | - | 690.6 | 557 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.